Drugs / AOXMED Poria γ-aminobutyric acid drink
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05908903 | Jul → Aug 2022 | sleep disorder | Botanee Group Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AOXMED Poria γ-aminobutyric acid drink | “The main objective of the study is to observe changes in the subjects' sleep quality, skin condition and life status after 4 weeks of using a sleep aid drink (AOXMED Poria...” NCT05908903 ↗ |
| Route | Oral | “subjects in the experimental group will take a drink with the active ingredients of Poria, Poria and GABA” NCT05908903 ↗ |